Hyperthermic modulation of resistance to cis-diammine-dichloroplatinum(II) in human larynx carcinoma cells

References

• Andrews P. A. Mechanisms of acquired resistance to cisplatin. Anticancer Drug Resistance: Advances in Molecular and Clinical Research, R. F. Ozols, L. J. Goldstein. Kluwer Academic Publishers, Boston 1994; 217–248
   Google Scholar
• Beketi‐Orekovi L., Osmak M. Human larynx carcinoma cells resistant to cis‐diamminedichloroplatinum(II): Cross resistance patterns. Neoplasma 1994; 41: 171–176
   PubMedGoogle Scholar
• Beketi‐Orekovi L., Osmak M., Jaki M. Human larynx carcinoma cells resistant to cis‐diamminedichloroplatinum(II): mechanisms involved in the resistance. Neoplasma 1994; 41: 163–169
   PubMedGoogle Scholar
• Beketi‐Orekovi L., Osmak M. Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells. Cancer Chemotherapy Pharmacology 1995; 35: 327–333
   PubMedGoogle Scholar
• Calsou P., Salles B. Role of DNA repair in the mechanisms of cells resistance to alkylating agents and cisplatin. Cancer Chemotherapy Pharmacology 1993; 32: 85–89
   PubMedGoogle Scholar
• Eicholtz‐Wirth H., Hietel B. Heat sensitization to cisplatin in two cell lines with different drug sensitivities. International Journal of Hyperthermia 1990; 6: 47–55
   PubMedGoogle Scholar
• Engin K. Biological rationale for hyperthermia in cancer treatment (II). Neoplasma 1994a; 41: 277–283
   PubMed Web of Science ®Google Scholar
• Engin K. Hyperthermia in cancer treatment (I). Neoplasma 1994b; 41: 269–276
   PubMedGoogle Scholar
• Epelbaum R., Teicher B., Holden S. A., Ara G., Varshney A., Herman T. S. Interaction of D, L‐ and D‐ tetraplatin with hyperthermia in vitro and in vivo. European Journal of Cancer 1992; 28: 794–800
   Google Scholar
• Freeman M. L., Meredith M. J., Eisert D. R. Failure of chronic glutathione elevation to reduce cytotoxicity produced by exposure to cis‐diammine‐dichloroplatinum(II), ionizing radiation, or hyperthermia. Cancer Research 1990; 50: 5296–5300
   PubMedGoogle Scholar
• Gately D. P., Howell S. B. Cellular accumulation of the anticancer agent cisplatin. A review. British Journal of Cancer 1993; 67: 1171–1176
   PubMed Web of Science ®Google Scholar
• Herman T. S., Teicher B. A., Cathcart K. N. S., Kaufmann M. E., Lee J. B., Lee M. ‐H. Effect of hyperthermia on cis‐diamminedichloroplatinum(II) (rhodamine 123)2 (tetrachloroplatinum(II)) in a human squamous cell carcinoma line and a cis‐ diamminedichloroplatinum(II)‐resistant subline. Cancer Research 1988; 48: 5101–5105
   PubMed Web of Science ®Google Scholar
• Hettinga J. V. E., Lemstra W., Meijer C., Mulder N. H., Konings A. W. T., Devries E. G. E., Kampinga H. H. Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant subline. International Journal of Hyperthermia 1994; 10: 795–805
   PubMed Web of Science ®Google Scholar
• Hettinga J. V. E., Lemstra W., Devries E. G. E., Konings A. W. T., Kampinga H. H. Sensitization to cisplatin action by step‐down heating in CDDP‐sensitive and ‐resistant cells. International Journal of Cancer 1995; 61: 722–726
   PubMedGoogle Scholar
• Issels R. D. Clinical rationale for thermochemotherapy. Thermoradiotherapy and thermochemotherapy, M. H. Seegenschmiedt, P. Fessenden, C. C. Vernon. Springer, New York 1996; 25–33
   Google Scholar
• Kimura E., Howell S. B. Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line. Cancer Chemotherapy Pharmacology 1993; 32: 419–424
   PubMedGoogle Scholar
• Konings A. W. T., Hettinga J. V. E., Lemstra W., Humphrey G. B., Kampinga H. H. Sensitizing for cis‐diamminedichloro‐platinum(II) action by hyperthermia in resistant cells. International Journal of Hyperthermia 1993; 9: 553–562
   PubMed Web of Science ®Google Scholar
• Leniar H., Budihna M. Potentials of hyperthermia in clinical use. Advanced Radiology and Oncology. 1992; 284–298
   Google Scholar
• Malmquist K. G. Quantitative PIXE analysis of biomedical material‐sample preparation, irradiation and quality control. Particle induced X‐ray emission and its analytical applications, R. D. Vis. North Holland, Amsterdam 1988; 183–190
   Google Scholar
• Mansouri A., Henle K. J., Benson A. M., Moss A. J., Nagle W. A. Characterization of a cisplatin‐resistant subline of murine RIF‐1 cells and reversal of drug resistance by hyperthermia. Cancer Research 1989; 49: 2674–2678
   PubMed Web of Science ®Google Scholar
• Mitchell J. B., Cook J., DeGraaf W., Glatstein E., Russo A. Glutathione modulation in cancer treatment: will it work? (Keynote address). International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1289–1295
   PubMedGoogle Scholar
• Nakata B., Barton R. M., Robbins K. T., Howell S. B., Loss G. Association between hsp60 mRNA levels and cisplatin resistance in human head and neck cancer cell lines. Oncology 1994; 5: 1425–1432
   Google Scholar
• Neilan B. A., Henle K. J., Nagle W. A., Moss A. J. Cytotoxicity of hyperthermia combined with Bleomycin or cis‐Platinum in cultured RIF cells; modification by thermotholerance and by polyhydroxy compounds. Cancer Research 1986; 46: 2245–2251
   PubMed Web of Science ®Google Scholar
• Osmak M. Collateral resistance or sensitivity of human larynx carcinoma HEp2 cells resistant to cis‐diamminedichloro‐platinum(II) or vincristine sulfate. Neoplasma 1992; 39: 197–202
   PubMedGoogle Scholar
• Osmak M., Beketi‐Oreskovi L., Matuli M., Sori J. Resistance of human larynx carcinoma cells to cisplatin, gamma irradiation and methotrexate do not involve overexpression of c‐myc or c‐Ki‐ras oncogenes. Mutation Research 1993; 303: 113–120
   PubMedGoogle Scholar
• Overgaard J., Horsman M. R. Hyperthermia. Basic clinical radiohiology, G. Gordon Steel. Edward Arnold, London 1993; 173–184
   Google Scholar
• Raaphorst G. P., Chabot P., Doja S., Wilkins D., Stewart D., Ng C. E. Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment. International Journal of Hyperthermia 1996a; 129: 211–222
   Google Scholar
• Raaphorst G. P., Doja S., Davis L., Stewart D., Ng C. E. A comparison of hyperthermia cisplatin sensitisation in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemotherapy and Pharmacology 1996b; 37: 574–580
   PubMedGoogle Scholar
• Raaphorst G. P., Yang D. P., Grewaal D., Goel R., Ng C. E. Analysis of mechanisms of cisplatin resistance in three pairs of human tumour cell lines expressing normal and resistant responses to cisplatin. Oncology Reports 1995; 2: 1037–1043
   PubMedGoogle Scholar
• Scanlon K. J., Kashani‐Sabet M., Tone T., Funato T. Cisplatin resistance in human cancers. Pharmocology Therapy 1991; 52: 385–406
   PubMed Web of Science ®Google Scholar
• Shchepotin I. B., Shabahang M., Nauta R. J., Buras R. R., Brenner R. V., Evans S. R. T. Antitumor activity of 5‐fluorouracil, verapamil and hyperthermia against human gastric adenocarcinoma cell (AGS) in vitro. Surgical Oncology 1994; 3: 287–294
   PubMedGoogle Scholar
• Stewart D. J., Evans W. K. Non‐chemotherapeutic agents that potentiate chemotherapy efficacy. Cancer Treatment Review 1989; 16: 1–40
   PubMed Web of Science ®Google Scholar
• Timmer‐Boscha H., Mulder N. H., De Vries E. G. E. Modulation of cis‐diamminedichloroplatinum(II) resistance: a review. British Journal of Cancer 1992; 66: 227–233
   PubMedGoogle Scholar
• Urano M., Begly J., Reynolds R. Interaction between adriamycin cytotoxicity and hyperthermia: growth‐phase‐dependent thermal sensitization. International Journal of Hyperthermia 1994; 10: 817–826
   PubMed Web of Science ®Google Scholar
• Vernon C. Hyperthermia in cancer growth regulation. Biotherapy 1992; 4: 307–315
   PubMedGoogle Scholar
• Wallner K. E., De Gregorio M. W., Li G. C. Hyperthermic potentiation of cis‐diamminedichloroplatinum(II) cytotoxicity in Chinese Hamster Ovary cells resistant to the drug. Cancer Research 1986; 46: 6242–6245
   PubMed Web of Science ®Google Scholar
• Waxman D. J. Glutathione S‐transferases: role in alkylating agent resistance and possible target for modulation chemotherapy—a review. Cancer Research 1990; 50: 6449–6454
   PubMed Web of Science ®Google Scholar
• Yano T., Nakatani K., Watanabe A., Nakano H., Ohnishi T. Effects of preheating on cis‐diamminedichloro‐platinum(II)‐hyperthermia‐induced tumour growth depression of transplantable human oesophageal cancer to nude mice. International Journal of Hyperthermia 1993; 9: 699–708
   PubMed Web of Science ®Google Scholar